首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1572540

白血球分离术市场、机会、成长动力、产业趋势分析与预测，2024-2032

Leukapheresis Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月22日 | 出版商:

Global Market Insights Inc. | 英文 195 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年白血球去除术市场价值约为 2.818 亿美元，预计 2024 年至 2032 年复合年增长率为 12.7%。该过程包括抽取血液，透过机器过滤以分离白血球，然后将剩余的血液成分（例如红血球和血小板）返回给患者。

血癌发生率的上升是推动市场成长的主要因素。对有效治疗的需求不断增加，增加了对白血球去除术的需求，白血球去除术在通过去除异常白血球和改善患者预后来控制这些疾病方面发挥着至关重要的作用。此外，白血球分离设备和方法的创新，以及对免疫疗法和细胞疗法的日益关注，正在进一步支持市场。政府政策和措施也透过促进技术进步和改善获得护理的机会来促进市场扩张。

整个白血球分离术产业根据产品、应用、最终用途和地区进行分类。

依产品划分，白血球分离术市场分为一次性用品和设备。预计到2032 年，包括白血球分离装置和管道在内的一次性产品将达到5.026 亿美元。的安全性和效率。

根据应用，市场分为治疗和研究领域。治疗领域到 2023 年将达到 1.555 亿美元，包括血液学疾病和自体免疫疾病的治疗。白血球分离术可以针对性地收集特定的白血球，从而提高免疫疗法和干细胞移植等治疗的有效性。它还可以透过清除血液中的有害抗体和免疫复合物来帮助控制自体免疫疾病。

按最终用途划分，市场分为血液成分供应商和血液中心、学术和研究机构、製药和生物技术公司以及医院和输血中心。到 2032 年，医院和输血中心预计将达到 2.977 亿美元，其中白血球去除术能够有效收集和分离白血球，用于各种治疗，包括癌症免疫治疗。

在技术进步和癌症治疗需求不断增长的推动下，美国白血球去除术市场预计将大幅增长，到 2032 年将达到 2.805 亿美元。

产业生态系统分析
产业影响力
- 成长动力
  - 血癌及相关疾病病例不断增加
  - 白血球分离装置及其程序的创新
  - 研发激增，重点在于细胞疗法和免疫疗法
  - 政府的支持性措施和政策
- 产业陷阱与挑战
  - 昂贵的白血球分离设备
  - 缺乏训练有素的专业人员
成长潜力分析
监管环境
技术景观
- 核心技术
- 邻近技术
定价分析
未来市场趋势
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
免洗用品
装置
- 离心装置
- 膜分离器
- 其他设备

第 6 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
治疗性
- 血液学疾病
- 自体免疫疾病
- 其他治疗应用
研究
- 癌症研究
- 免疫学研究
- 其他研究应用

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
血液成分提供者和血液中心
学术及研究机构
製药和生物技术公司
医院及输血中心

第 8 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

Asahi Kasei Corporation
Beijing ZKSK Technology Co., Ltd.
Baxter International Inc.
Cardinal Health, Inc.
Fresenius SE and Co. KGaA
Guangzhou DaJi Medical Science and Technology Co., Ltd.
Haemonetics Corporation
Macopharma
Medica SPA
Miltenyi Biotec
Mitra Industries Private Limited
Nikkiso Co. Ltd.
Puriblood Medical Co. Ltd.
SB-Kawasumi Laboratories, Inc.
Terumo BCT, Inc.

简介目录

Product Code: 10924

The Leukapheresis Market was valued at approximately USD 281.8 million in 2023 and is expected to grow at a CAGR of 12.7% from 2024 to 2032. Leukapheresis is a specialized medical procedure that extracts and collects white blood cells (leukocytes) from the bloodstream. The process involves drawing blood, filtering it through a machine to isolate the leukocytes, and then returning the remaining blood components, such as red blood cells and platelets, back to the patient.

The rising incidence of blood cancer is a major factor driving market growth. The increasing need for effective treatments has boosted the demand for leukapheresis, which plays a crucial role in managing these conditions by removing abnormal white blood cells and improving patient outcomes. Moreover, innovations in leukapheresis devices and methodologies, alongside a growing focus on immunotherapy and cell-based therapies, are further supporting the market. Government policies and initiatives also contribute to market expansion by fostering technological advancements and improving access to care.

The overall Leukapheresis industry is segregated based on Product, Application, End-use, and Region.

By product, the leukapheresis market is divided into disposables and devices. The disposable segment, including leukapheresis sets and tubing, is projected to reach USD 502.6 million by 2032. Disposables help reduce the risk of cross-contamination, eliminate the need for sterilization processes, and simplify procedures, enhancing both safety and efficiency in medical settings.

By application, the market is categorized into therapeutic and research segments. The therapeutic segment, which accounted for USD 155.5 million in 2023, includes treatments for hematology disorders and autoimmune diseases. Leukapheresis allows for the targeted collection of specific white blood cells, improving the effectiveness of treatments like immunotherapy and stem cell transplantation. It also aids in managing autoimmune conditions by removing harmful antibodies and immune complexes from the bloodstream.

By end-use, the market is segmented into blood component providers and blood centers, academic and research institutes, pharmaceutical and biotechnology companies, and hospital and transfusion centers. Hospitals and transfusion centers are expected to reach USD 297.7 million by 2032, with leukapheresis enabling efficient collection and separation of leukocytes for various treatments, including cancer immunotherapy.

The U.S. leukapheresis market is anticipated to grow significantly, reaching USD 280.5 million by 2032, driven by advancements in technology and the growing need for cancer treatments.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising cases of blood cancer and related disorders
  - 3.2.1.2 Innovations in leukapheresis devices and their procedures
  - 3.2.1.3 Surge in R&D focus on cell-based therapies and immunotherapy
  - 3.2.1.4 Supportive government initiatives and policies
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Expensive leukapheresis devices
  - 3.2.2.2 Shortage of trained professionals
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
3.6 Pricing analysis
3.7 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Disposables
5.3 Devices
- 5.3.1 Centrifugal devices
- 5.3.2 Membrane separators
- 5.3.3 Other devices

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Therapeutic
- 6.2.1 Hematology disorders
- 6.2.2 Autoimmune diseases
- 6.2.3 Other therapeutic applications
6.3 Research
- 6.3.1 Cancer research
- 6.3.2 Immunology research
- 6.3.3 Other research applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Blood component providers and blood centers
7.3 Academic and research institutes
7.4 Pharmaceutical and biotechnology companies
7.5 Hospital and transfusion centers

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa